BJDX logo

BJDX Bluejay Diagnostics, Inc.

NASDAQ Capital Market · Medical - Devices · Healthcare

$2.61
+0.01 (+0.19%)

Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also inclu…

Market Cap: $2.92Mbluejaydx.com

Price

No data yet.

Social Signal Score

41
5d
—
30d
—
60d
37
3 mentions
—
90d
45
4 mentions
—
news: 4

Analyst Ratings

1 analyst
Holdconsensus
Strong Buy 0Buy 0Hold 1Sell 0Strong Sell 0

Revenue

$0.00
$0.00$83.0K$166.0K$249.0K
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-2048.00
$-2048.00–$-2048.00
1 analysts
FY2026
$-1856.00
$-1856.00–$-1856.00
1 analysts
FY2027
$-128.00
$-128.00–$-128.00
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Indranil Dey
Sector
Healthcare
Industry
Medical - Devices
Employees
6
Beta
0.92
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-8.22
bluejaydx.com